IL72623A - Externalization of products of bacteria and dna fragment therefor - Google Patents

Externalization of products of bacteria and dna fragment therefor

Info

Publication number
IL72623A
IL72623A IL72623A IL7262384A IL72623A IL 72623 A IL72623 A IL 72623A IL 72623 A IL72623 A IL 72623A IL 7262384 A IL7262384 A IL 7262384A IL 72623 A IL72623 A IL 72623A
Authority
IL
Israel
Prior art keywords
externalization
bacteria
products
dna fragment
product
Prior art date
Application number
IL72623A
Other versions
IL72623A0 (en
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of IL72623A0 publication Critical patent/IL72623A0/en
Publication of IL72623A publication Critical patent/IL72623A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)

Abstract

A bacterial product is made by transforming a temperature sensitive lysogen with a DNA molecule which codes, directly or indirectly, for the product, culturing the transformant under permissive conditions and externalizing the product by raising the temperature to induce phage encoded functions.
IL72623A 1983-08-09 1984-08-08 Externalization of products of bacteria and dna fragment therefor IL72623A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/521,517 US4637980A (en) 1983-08-09 1983-08-09 Externalization of products of bacteria

Publications (2)

Publication Number Publication Date
IL72623A0 IL72623A0 (en) 1984-11-30
IL72623A true IL72623A (en) 1990-04-29

Family

ID=24077058

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72623A IL72623A (en) 1983-08-09 1984-08-08 Externalization of products of bacteria and dna fragment therefor

Country Status (20)

Country Link
US (1) US4637980A (en)
EP (1) EP0140864B1 (en)
JP (3) JPH0698018B2 (en)
KR (1) KR940004545B1 (en)
AT (1) ATE51024T1 (en)
AU (1) AU583014B2 (en)
CA (1) CA1219825A (en)
DE (1) DE3481629D1 (en)
DK (1) DK172672B1 (en)
ES (2) ES534963A0 (en)
FI (1) FI89507C (en)
GR (1) GR80053B (en)
HU (1) HU197940B (en)
IE (1) IE57797B1 (en)
IL (1) IL72623A (en)
NO (1) NO169242C (en)
NZ (1) NZ209128A (en)
PT (1) PT79045A (en)
ZA (1) ZA846132B (en)
ZW (1) ZW12684A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894334A (en) * 1984-03-28 1990-01-16 Cetus Corporation Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit
US5162217A (en) * 1984-08-27 1992-11-10 Bio-Technology General Corp. Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda PL promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof
US5759816A (en) * 1984-08-27 1998-06-02 Bio-Technology General Corp. Expression vectors containing λPL promoter and T1 T2 rRNA termination sequence plasmids containing the vectors hosts containing the plasmids and related methods
TW205070B (en) * 1986-06-30 1993-05-01 Takeda Pharm Industry Co Ltd
US5646015A (en) * 1988-08-31 1997-07-08 Astra Ab Excretion of heterologous proteins from E. coli
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
US5198346A (en) * 1989-01-06 1993-03-30 Protein Engineering Corp. Generation and selection of novel DNA-binding proteins and polypeptides
US5096815A (en) * 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
DE4023721A1 (en) * 1990-07-26 1992-01-30 Boehringer Mannheim Gmbh Modified Gram negative bacteria for use as vaccine and adjuvant - are transformed to express lytic protein or toxin, forming ghost(s) which present many cell wall epitope(s)
US6177083B1 (en) * 1990-07-26 2001-01-23 Evax Technologies Gmbh Process for the production of vaccines and their use
GB9223709D0 (en) * 1992-11-12 1992-12-23 Ici Plc Process for the separation of protein from microorganisms
US5468629A (en) * 1993-04-13 1995-11-21 Calhoun; Cornelia Method of promoting in vitro homologous recombination transfection in mammalian cells using the RecA protein
SE9702401D0 (en) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
DK1323820T3 (en) * 1998-10-28 2009-03-16 Genentech Inc Method for Facilitated Isolation of Heterologous Proteins from Bacterial Cells
US7858339B1 (en) 1998-10-28 2010-12-28 Genentech, Inc. Process for bacterial production of polypeptides
US6268178B1 (en) * 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
US6479280B1 (en) * 1999-09-24 2002-11-12 Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
DE60127561T2 (en) * 2000-08-15 2007-12-13 Phage Biotechnology Corp., Tustin PHAGEN-DEPENDENT SUPER PRODUCTION OF BIOLOGICALLY ACTIVE PROTEINS AND PEPTIDES
EP1309716A4 (en) * 2000-08-15 2005-08-03 Phage Biotechnology Corp A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
PL2327718T3 (en) 2003-11-21 2016-10-31 Improved expression systems with SEC-system secretion
JP2007512842A (en) * 2003-12-01 2007-05-24 ダウ グローバル テクノロジーズ インコーポレイティド Production of recombinant icosahedral virus-like particles in Pseudomonas
CA2574953A1 (en) 2004-07-26 2006-02-09 Dow Global Technolgies Inc. Process for improved protein expression by strain engineering
US7892811B2 (en) * 2004-08-17 2011-02-22 Zymo Research Corporation Controlled lysis of bacteria
AU2008210538B2 (en) 2007-01-31 2013-06-06 Pelican Technology Holdings, Inc. Bacterial leader sequences for increased expression
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
JP5444553B2 (en) 2007-04-27 2014-03-19 フェネックス インコーポレイテッド Methods for rapidly screening microbial hosts to identify specific strains with improved yield and / or quality of heterologous protein expression
CN101784655A (en) * 2007-04-27 2010-07-21 菲尼克斯股份有限公司 Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
WO2009025690A2 (en) * 2007-05-23 2009-02-26 Nature Technology Corporation Improved e. coli plasmid dna production
WO2009076196A1 (en) * 2007-12-07 2009-06-18 Dow Global Technologies Inc. High copy number self-replicating plasmids in pseudomonas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336336A (en) 1979-01-12 1982-06-22 President And Fellows Of Harvard College Fused gene and method of making and using same
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US4506013A (en) * 1980-10-03 1985-03-19 Eli Lilly And Company Stabilizing and selecting recombinant DNA host cells
EP0061250A3 (en) * 1981-03-23 1983-09-28 Biogen N.V. Improved process for recovering products produced by host organisms
CA1185197A (en) * 1981-04-30 1985-04-09 Akira Furuya Lysozyme-sensitive microorganism
EP0074808A3 (en) * 1981-09-16 1984-07-04 University Patents, Inc. Recombinant method and materials

Also Published As

Publication number Publication date
JPH07115974A (en) 1995-05-09
ZW12684A1 (en) 1984-11-21
FI843104A0 (en) 1984-08-07
JPH0787787B2 (en) 1995-09-27
CA1219825A (en) 1987-03-31
FI843104L (en) 1985-02-10
IL72623A0 (en) 1984-11-30
ES8602124A1 (en) 1985-11-01
JPH0714348B2 (en) 1995-02-22
ATE51024T1 (en) 1990-03-15
EP0140864B1 (en) 1990-03-14
JPH0698018B2 (en) 1994-12-07
HUT35010A (en) 1985-05-28
US4637980A (en) 1987-01-20
HU197940B (en) 1989-06-28
NZ209128A (en) 1990-06-26
IE57797B1 (en) 1993-04-07
NO169242B (en) 1992-02-17
FI89507B (en) 1993-06-30
GR80053B (en) 1984-12-12
KR850001530A (en) 1985-03-30
JPS6062985A (en) 1985-04-11
ES543207A0 (en) 1987-02-16
DK380684D0 (en) 1984-08-07
AU583014B2 (en) 1989-04-20
DK172672B1 (en) 1999-05-10
AU3163884A (en) 1985-02-14
IE842021L (en) 1985-02-09
DE3481629D1 (en) 1990-04-19
ES534963A0 (en) 1985-11-01
NO843183L (en) 1985-02-11
NO169242C (en) 1992-05-27
DK380684A (en) 1985-02-10
ZA846132B (en) 1985-06-26
EP0140864A1 (en) 1985-05-08
FI89507C (en) 1993-10-11
KR940004545B1 (en) 1994-05-25
PT79045A (en) 1984-09-01
JPH06121691A (en) 1994-05-06
ES8703524A1 (en) 1987-02-16

Similar Documents

Publication Publication Date Title
IL72623A (en) Externalization of products of bacteria and dna fragment therefor
YU26084A (en) Process for producing plazmides expression for producing heterologic polypeptide article in e. coli bacteria
DE69016012D1 (en) Neue hyperthermostabile alpha - amylase.
IL73496A0 (en) Polyethyleneimine bound chromatographic packing
ES8505408A1 (en) Process for producing proteins correlated with the diphtheric toxin
EP0176971A3 (en) Gene coding for thermostable beta-galactosidase, bacillus subtilis having the gene, enzyme coded by the gene and a process for the production thereof
EP0163623A3 (en) Cell surface protein, process for its preparation, as well as the use of a cell surface protein thus obtained
AU588793B2 (en) Method of expressing alpha-1-antitrypsin in bacteria
EP0274873A3 (en) Antibiotic a10255 complex and factors, process, microorganisms for its production
EP0077664A3 (en) Recombinant dna and coliform bacillus having genetic material for the production of staphylokinase, and the production of staphylokinase
ZA828570B (en) Process for fermenting carbohydrate- and phosphate-containing liquid media
JO1344B1 (en) Externalization of Products of Bacteria
EP0049801A3 (en) Sucrose-mutase, immobilized sucrose-mutase and use of this immobilized sucrose-mutase for the production of isomaltulose(6-o-alpha-d-glucopyranosido-d fructose)
EP0220714A3 (en) Dna fragment containing the cyclodextrin-glycosyl-transferase gene, expression vector, microorganisms for expression and preparation process
DE3370652D1 (en) Bacillus subtilis dsm 2704 and process for the preparation of alpha-amylase
GB1413224A (en) Purifying 1,4-dicyanobutenes
BR8401672A (en) CLOSTRIDIUM BOTULINUM GROWTH INHIBITION PROCESS IN MEAT PRODUCTS
EP0413615A3 (en) Process for the protection and conservation of micro-organisms, particularly of bacteria
DE3682379D1 (en)
MY102317A (en) Novel microorganisms and a method for production of glutamic acid using the same.
MX9602206A (en) Sulfide-oxidizing bacteria and process therewith.
EP0406621A3 (en) Process for the preparation of condensed milk
ES8701687A1 (en) Sodium metabisulphite prodn.
RO100410A2 (en) Black-coloured porcelain
SU1773070A1 (en) Construction steel for springs

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees